{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:15:27Z","timestamp":1790828127085,"version":"4.1.0"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Specialist Biomedical Research Center for Mental Health"},{"DOI":"10.13039\/100013376","name":"Institute of Psychiatry, Psychology and Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013376","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHS"},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The variability in the response to antipsychotic medication in schizophrenia may reflect between-patient differences in neurobiology. Recent cross-sectional neuroimaging studies suggest that a poorer therapeutic response is associated with relatively normal striatal dopamine synthesis capacity but elevated anterior cingulate cortex (ACC) glutamate levels. We sought to test whether these measures can differentiate patients with psychosis who are antipsychotic responsive from those who are antipsychotic nonresponsive in a multicenter cross-sectional study. 1H-magnetic resonance spectroscopy (1H-MRS) was used to measure glutamate levels (Glucorr) in the ACC and in the right striatum in 92 patients across 4 sites (48 responders [R] and 44 nonresponders [NR]). In 54 patients at 2 sites (25 R and 29 NR), we additionally acquired 3,4-dihydroxy-6-[18F]fluoro-l-phenylalanine (18F-DOPA) positron emission tomography (PET) to index striatal dopamine function (Kicer, min\u22121). The mean ACC Glucorr was higher in the NR than the R group after adjustment for age and sex (F1,80 = 4.27; P = .04). This was associated with an area under the curve for the group discrimination of 0.59. There were no group differences in striatal dopamine function or striatal Glucorr. The results provide partial further support for a role of ACC glutamate, but not striatal dopamine synthesis, in determining the nature of the response to antipsychotic medication. The low discriminative accuracy might be improved in groups with greater clinical separation or increased in future studies that focus on the antipsychotic response at an earlier stage of the disorder and integrate other candidate predictive biomarkers. Greater harmonization of multicenter PET and 1H-MRS may also improve sensitivity.<\/jats:p>","DOI":"10.1093\/schbul\/sbaa128","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T15:15:50Z","timestamp":1598022950000},"page":"505-516","source":"Crossref","is-referenced-by-count":88,"title":["Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)"],"prefix":"10.1093","volume":"47","author":[{"given":"Alice","family":"Egerton","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Murphy","sequence":"additional","affiliation":[{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Donocik","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Anton","sequence":"additional","affiliation":[{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"},{"name":"Academic Unit of Radiology, Medical School, Faculty of Medicine, Dentistry & Health, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J","family":"Barker","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Collier","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Deakin","sequence":"additional","affiliation":[{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-4835","authenticated-orcid":false,"given":"Richard","family":"Drake","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Eliasson","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1218-675X","authenticated-orcid":false,"given":"Richard","family":"Emsley","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J","family":"Gregory","sequence":"additional","affiliation":[{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitij","family":"Kapur","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kassoumeri","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Knight","sequence":"additional","affiliation":[{"name":"CUBRIC, School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J B","family":"Lambe","sequence":"additional","affiliation":[{"name":"CUBRIC, School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Lawrie","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lees","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sh\u00f4n","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Lythgoe","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Matthews","sequence":"additional","affiliation":[{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-8920","authenticated-orcid":false,"given":"Lily","family":"McNamee","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Semple","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D","family":"Shaw","sequence":"additional","affiliation":[{"name":"CUBRIC, School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish D","family":"Singh","sequence":"additional","affiliation":[{"name":"CUBRIC, School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Stockton-Powdrell","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Talbot","sequence":"additional","affiliation":[{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Veronese","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Wagner","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T R","family":"Walters","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H","family":"MacCabe","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D","family":"Howes","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Psychiatric Imaging Group, MRC London Institute of Medical Sciences, Hammersmith Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"issue":"9618","key":"2021031702310882700_CIT0001","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet."},{"issue":"2-3","key":"2021031702310882700_CIT0002","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","article-title":"Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)","volume":"115","author":"Boter","year":"2009","journal-title":"Schizophr Res."},{"issue":"12","key":"2021031702310882700_CIT0003","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med."},{"issue":"2 Suppl","key":"2021031702310882700_CIT0004","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry."},{"key":"2021031702310882700_CIT0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2012.12.004","article-title":"Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA","volume":"86","author":"Mullins","year":"2014","journal-title":"Neuroimage."},{"issue":"1","key":"2021031702310882700_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2013the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr Med Res Opin."},{"issue":"6","key":"2021031702310882700_CIT0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br J Psychiatry."},{"key":"2021031702310882700_CIT0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psychres.2017.01.064","article-title":"The critical treatment window of clozapine in treatment-resistant schizophrenia: secondary analysis of an observational study","volume":"250","author":"Yoshimura","year":"2017","journal-title":"Psychiatry Res."},{"issue":"1","key":"2021031702310882700_CIT0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry."},{"issue":"7","key":"2021031702310882700_CIT0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0269881109106959","article-title":"Review: The biological basis of antipsychotic response in schizophrenia","volume":"24","author":"Stone","year":"2010","journal-title":"J Psychopharmacol."},{"issue":"15","key":"2021031702310882700_CIT0011","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1017\/S0033291716002014","article-title":"Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses","volume":"46","author":"Lally","year":"2016","journal-title":"Psychol Med."},{"issue":"11","key":"2021031702310882700_CIT0012","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1017\/S0033291717000435","article-title":"Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors","volume":"47","author":"Demjaha","year":"2017","journal-title":"Psychol Med"},{"issue":"4","key":"2021031702310882700_CIT0013","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S2215-0366(15)00575-1","article-title":"Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study","volume":"3","author":"Wimberley","year":"2016","journal-title":"Lancet Psychiatry."},{"issue":"3","key":"2021031702310882700_CIT0014","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/schbul\/sbv151","article-title":"Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive","volume":"42","author":"Mouchlianitis","year":"2016","journal-title":"Schizophr Bull."},{"issue":"1","key":"2021031702310882700_CIT0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","article-title":"The role of genes, stress, and dopamine in the development of schizophrenia","volume":"81","author":"Howes","year":"2017","journal-title":"Biol Psychiatry."},{"issue":"7","key":"2021031702310882700_CIT0016","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"7","key":"2021031702310882700_CIT0017","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1176\/ajp.146.7.905","article-title":"Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia","volume":"146","author":"Wolkin","year":"1989","journal-title":"Am J Psychiatry."},{"issue":"3","key":"2021031702310882700_CIT0018","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0033291700025575","article-title":"Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study","volume":"23","author":"Pilowsky","year":"1993","journal-title":"Psychol Med."},{"issue":"1","key":"2021031702310882700_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","article-title":"A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)","volume":"205","author":"Howes","year":"2014","journal-title":"Br J Psychiatry."},{"issue":"11","key":"2021031702310882700_CIT0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","article-title":"Dopamine synthesis capacity in patients with treatment-resistant schizophrenia","volume":"169","author":"Demjaha","year":"2012","journal-title":"Am J Psychiatry."},{"issue":"4","key":"2021031702310882700_CIT0021","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/npp.2016.258","article-title":"Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [18F]DOPA PET Study","volume":"42","author":"Kim","year":"2017","journal-title":"Neuropsychopharmacology."},{"issue":"14","key":"2021031702310882700_CIT0022","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2021031702310882700_CIT0023","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/schbul\/sbu220","article-title":"Striatal D(2\/3) binding potential values in drug-na\u00efve first-episode schizophrenia patients correlate with treatment outcome","volume":"41","author":"Wulff","year":"2015","journal-title":"Schizophr Bull."},{"issue":"10","key":"2021031702310882700_CIT0024","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-018-0042-4","article-title":"Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study","volume":"24","author":"Jauhar","year":"2019","journal-title":"Mol Psychiatry."},{"issue":"1","key":"2021031702310882700_CIT0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology."},{"issue":"11","key":"2021031702310882700_CIT0026","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2012.113","article-title":"Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia","volume":"37","author":"Egerton","year":"2012","journal-title":"Neuropsychopharmacology."},{"issue":"7","key":"2021031702310882700_CIT0027","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.biopsych.2018.09.009","article-title":"Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study","volume":"85","author":"Iwata","year":"2019","journal-title":"Biol Psychiatry."},{"issue":"4","key":"2021031702310882700_CIT0028","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41386-019-0589-z","article-title":"Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study","volume":"45","author":"Tarumi","year":"2020","journal-title":"Neuropsychopharmacology."},{"issue":"11","key":"2021031702310882700_CIT0029","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)","volume":"23","author":"Egerton","year":"2018","journal-title":"Mol Psychiatry."},{"key":"2021031702310882700_CIT0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2013.04.051","article-title":"Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia","volume":"547","author":"Szulc","year":"2013","journal-title":"Neurosci Lett."},{"issue":"9","key":"2021031702310882700_CIT0031","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/npp.2011.65","article-title":"Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis","volume":"36","author":"de la Fuente-Sandoval","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2021031702310882700_CIT0032","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance spectroscopy study with implications for glial dysfunction","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr Bull."},{"issue":"6","key":"2021031702310882700_CIT0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu117","article-title":"Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia","volume":"18","author":"Goldstein","year":"2015","journal-title":"Int J Neuropsychopharmacol."},{"issue":"10","key":"2021031702310882700_CIT0034","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","article-title":"Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study","volume":"70(","author":"de la Fuente-Sandoval","year":"2013","journal-title":"JAMA psychiatry."},{"issue":"6","key":"2021031702310882700_CIT0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2017.09.028","article-title":"Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients","volume":"83","author":"de la Fuente-Sandoval","year":"2018","journal-title":"Biol Psychiatry."},{"key":"2021031702310882700_CIT0036","first-page":"e11","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume-title":"Biol Psychiatry","author":"Demjaha","year":"2013"},{"key":"2021031702310882700_CIT0037","first-page":"18com12123","article-title":"Clinical guidance on the identification and management of treatment-resistant schizophrenia","volume-title":"J Clin Psychiatry","author":"Kane","year":"2019"},{"issue":"5","key":"2021031702310882700_CIT0038","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol Psychiatry."},{"key":"2021031702310882700_CIT0039","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2021031702310882700_CIT0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.jcp.0000117422.05703.ae","article-title":"Dose response and dose equivalence of antipsychotics","volume":"24","author":"Davis","year":"2004","journal-title":"J Clin Psychopharmacol."},{"issue":"2","key":"2021031702310882700_CIT0041","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"issue":"416","key":"2021031702310882700_CIT0042","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta psychiatr Scand Suppl."},{"issue":"2-3","key":"2021031702310882700_CIT0043","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr Res."},{"issue":"7027","key":"2021031702310882700_CIT0044","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.312.7027.345","article-title":"Compliance therapy in psychotic patients: randomised controlled trial","volume":"312","author":"Kemp","year":"1996","journal-title":"BMJ."},{"issue":"6","key":"2021031702310882700_CIT0045","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med."},{"issue":"4","key":"2021031702310882700_CIT0046","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mrm.1910300405","article-title":"Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy","volume":"30","author":"Kreis","year":"1993","journal-title":"Magn Reson Med."},{"issue":"6","key":"2021031702310882700_CIT0047","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mrm.20901","article-title":"Use of tissue water as a concentration reference for proton spectroscopic imaging","volume":"55","author":"Gasparovic","year":"2006","journal-title":"Magn Reson Med."},{"issue":"4","key":"2021031702310882700_CIT0048","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/jcbfm.1993.85","article-title":"Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans","volume":"13","author":"Cumming","year":"1993","journal-title":"J Cereb Blood Flow Metab."},{"issue":"7","key":"2021031702310882700_CIT0049","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.44.7.1292","article-title":"The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson\u2019s disease","volume":"44","author":"Sawle","year":"1994","journal-title":"Neurology."},{"issue":"2","key":"2021031702310882700_CIT0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1361-8415(96)80011-9","article-title":"Automated 3-D registration of MR and CT images of the head","volume":"1","author":"Studholme","year":"1996","journal-title":"Med Image Anal."},{"issue":"11","key":"2021031702310882700_CIT0051","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00004647-199911000-00003","article-title":"Multiresolution analysis of emission tomography images in the wavelet domain","volume":"19","author":"Turkheimer","year":"1999","journal-title":"J Cereb Blood Flow Metab."},{"issue":"2","key":"2021031702310882700_CIT0052","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archpsyc.61.2.134","article-title":"Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study","volume":"61","author":"McGowan","year":"2004","journal-title":"Arch Gen Psychiatry."},{"issue":"3","key":"2021031702310882700_CIT0053","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum","volume":"23","author":"Martinez","year":"2003","journal-title":"J Cereb Blood Flow Metab."},{"issue":"10","key":"2021031702310882700_CIT0054","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/npp.2014.87","article-title":"Dopamine function in cigarette smokers: an [18F]-DOPA PET study","volume":"39","author":"Bloomfield","year":"2014","journal-title":"Neuropsychopharmacology."},{"issue":"4","key":"2021031702310882700_CIT0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations","volume":"5","author":"Patlak","year":"1985","journal-title":"J Cereb Blood Flow Metab."},{"issue":"1","key":"2021031702310882700_CIT0056","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroimage.2006.03.002","article-title":"Multi-resolution Bayesian regression in PET dynamic studies using wavelets","volume":"32","author":"Turkheimer","year":"2006","journal-title":"Neuroimage."},{"issue":"4","key":"2021031702310882700_CIT0057","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchemneu.2003.10.003","article-title":"The primate basal ganglia: parallel and integrative networks","volume":"26","author":"Haber","year":"2003","journal-title":"J Chem Neuroanat."},{"issue":"6","key":"2021031702310882700_CIT0058","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jmri.24123","article-title":"Effects of age and sex on the concentrations of glutamate and glutamine in the human brain","volume":"38","author":"H\u00e4del","year":"2013","journal-title":"J Magn Reson Imaging."},{"issue":"2","key":"2021031702310882700_CIT0059","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/npp.2016.172","article-title":"Altered glutamate and regional cerebral blood flow levels in schizophrenia: a 1H-MRS and pCASL study","volume":"42","author":"Wijtenburg","year":"2017","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"2021031702310882700_CIT0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in schizophrenia: a focused review and meta-analysis of \u00b9H-MRS studies","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr Bull."},{"issue":"5","key":"2021031702310882700_CIT0061","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.mri.2007.06.007","article-title":"Regional variations and the effects of age and gender on glutamate concentrations in the human brain","volume":"26","author":"Sailasuta","year":"2008","journal-title":"Magn Reson Imaging."},{"issue":"10","key":"2021031702310882700_CIT0062","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0006-3223(99)00117-1","article-title":"Neurotransmitter interactions in schizophrenia\u2013therapeutic implications","volume":"46","author":"Carlsson","year":"1999","journal-title":"Biol Psychiatry."},{"issue":"2","key":"2021031702310882700_CIT0063","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.brainresrev.2007.10.006","article-title":"Glutamate-dopamine-GABA interactions in the aging basal ganglia","volume":"58","author":"Mora","year":"2008","journal-title":"Brain Res Rev."},{"issue":"16","key":"2021031702310882700_CIT0064","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1113\/jphysiol.2012.235200","article-title":"Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core","volume":"590","author":"Wang","year":"2012","journal-title":"J Physiol."},{"issue":"12","key":"2021031702310882700_CIT0065","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1523\/JNEUROSCI.18-12-04588.1998","article-title":"Dopamine neurons make glutamatergic synapses in vitro","volume":"18","author":"Sulzer","year":"1998","journal-title":"J Neurosci."},{"issue":"10","key":"2021031702310882700_CIT0066","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2215-0366(18)30268-2","article-title":"The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study","volume":"5","author":"Jauhar","year":"2018","journal-title":"Lancet Psychiatry."},{"issue":"26","key":"2021031702310882700_CIT0067","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1523\/JNEUROSCI.0329-15.2015","article-title":"Prefrontal and striatal glutamate differently relate to striatal dopamine: potential regulatory mechanisms of striatal presynaptic dopamine function?","volume":"35","author":"Gleich","year":"2015","journal-title":"J Neurosci."},{"issue":"3","key":"2021031702310882700_CIT0068","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry."},{"issue":"1","key":"2021031702310882700_CIT0069","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/acps.12825","article-title":"Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia","volume":"137","author":"McCutcheon","year":"2018","journal-title":"Acta Psychiatr Scand."},{"issue":"4","key":"2021031702310882700_CIT0070","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuroimage.2005.11.014","article-title":"Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge","volume":"30","author":"Vernaleken","year":"2006","journal-title":"Neuroimage."},{"key":"2021031702310882700_CIT0071","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fpsyt.2017.00066","article-title":"Effects of antipsychotic administration on brain glutamate in schizophrenia: a systematic review of longitudinal 1H-MRS studies","volume":"8","author":"Egerton","year":"2017","journal-title":"Front Psychiatry."},{"issue":"1-3","key":"2021031702310882700_CIT0072","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2016.02.017","article-title":"Age-related changes in anterior cingulate cortex glutamate in schizophrenia: a (1)H-MRS study at 7 tesla","volume":"172","author":"Brandt","year":"2016","journal-title":"Schizophr Res."},{"issue":"7","key":"2021031702310882700_CIT0073","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"2021031702310882700_CIT0074","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1176\/appi.ajp.2015.14121571","article-title":"Baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment","volume":"173","author":"Sarpal","year":"2016","journal-title":"Am J Psychiatry."},{"issue":"4","key":"2021031702310882700_CIT0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2215-0366(15)00553-2","article-title":"Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach","volume":"3","author":"Ruderfer","year":"2016","journal-title":"Lancet Psychiatry."},{"issue":"5","key":"2021031702310882700_CIT0076","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/schbul\/sbx007","article-title":"Polygenic risk score for schizophrenia and treatment-resistant schizophrenia","volume":"43","author":"Wimberley","year":"2017","journal-title":"Schizophr Bull."},{"issue":"1","key":"2021031702310882700_CIT0077","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41398-018-0366-5","article-title":"Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study","volume":"9","author":"Martinuzzi","year":"2019","journal-title":"Transl Psychiatry."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/47\/2\/505\/36620472\/sbaa128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/47\/2\/505\/36620472\/sbaa128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T22:36:48Z","timestamp":1615934208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/47\/2\/505\/5903699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,9,10]]},"published-print":{"date-parts":[[2021,3,16]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaa128","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,9,10]]}}}